Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Orly Yariv"'
Publikováno v:
BioMedInformatics, Vol 4, Iss 1, Pp 158-172 (2024)
Radiation-induced gastrointestinal (GI) dose constraints are still a matter of concern with the ongoing evolution of patient outcomes and treatment-related toxicity in the era of image-guided intensity-modulated radiation therapy (IMRT), stereotactic
Externí odkaz:
https://doaj.org/article/00e535345e1a41bea1738cfc534f715d
Autor:
Yasmin Korzets, Orly Yariv, Raz Mutai, Assaf Moore, Tzippy Shochat, Rinat Yerushalmi, Hadar Goldvaser
Publikováno v:
Discover Oncology, Vol 12, Iss 1, Pp 1-13 (2021)
Abstract Background Menstrual and parity history might impact the risk for breast cancer. Data on the impact of these factors on other tumor characteristics are limited. Methods A single center retrospective cohort study comprising all women with est
Externí odkaz:
https://doaj.org/article/0dafa8a6c06c4a89a439ddfc3d07fd69
Autor:
Yosef Landman, Oded Jacobi, Noga Kurman, Orly Yariv, Idit Peretz, Ofer Rotem, Elizabeth Dudnik, Alona Zer, Aaron M. Allen
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
The standard of care for stage III non-small cell lung cancer (NSCLC) is chemoradiotherapy (CRT) followed by durvalumab. Although doses higher than 66 Gy are standard in our center, they were used in only 6.9% of patients in the PACIFIC trial. We rep
Externí odkaz:
https://doaj.org/article/137b1d142eab40229a53b83577ea701c
Publikováno v:
The Journal of Laryngology & Otology. :1-24
Autor:
Assaf Moore, Rinat Yerushalmi, Tzippy Shohat, Hadar Goldvaser, Orly Yariv, Yasmin Korzets Ceder, Ofer Rotem
Publikováno v:
Cancer Research. 81:PS8-21
Background: Oral contraceptives (OC) and hormone replacement therapy (HRT) are well-established risk factors for ER positive breast cancer. Infertility is associated with an increased breast cancer risk and there is conflicting data on the influence
Autor:
Assaf Moore, Rinat Yerushalmi, Raz Mutai, Daliah Tsoref, Tzippy Shochat, Ofer Rotem, Hadar Goldvaser, Yasmin Korzets, Orly Yariv
Publikováno v:
Oncology. 99:713-721
Introduction: The impact of exogenous estrogen exposure on breast cancer characteristics and outcomes is not well described. We aimed to investigate the effect of prior treatment with oral contraceptives (OCT), hormone replacement therapy (HRT), and
Autor:
Orly, Yariv, Alexandra, Benouaich-Amiel, Tanseem, Kab, Shlomit, Yust-Katz, Rinat, Yerushalmi, Hadar, Goldvaser
Publikováno v:
Harefuah. 161(1)
A 35 years old woman was diagnosed with clinical stage 2, grade 3, hormone receptor positive, human epidermal growth factor receptor 2 (HER2) negative invasive ductal carcinoma, with ki-67 of 60%. She was treated with neoadjuvant chemotherapy with do
Autor:
Orly Yariv, Rinat Yerushalmi, Assaf Moore, Hadar Goldvaser, Yasmin Korzets, Tzippy Shochat, Raz Mutai
Background: Menstrual and parity history might impact the risk for breast cancer. Data on the impact of these factors on other tumor characteristics are limited. Methods: A single center retrospective cohort study comprising all women with estrogen r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::371fffdbcfe73de78e22774485d96227
https://doi.org/10.21203/rs.3.rs-618743/v1
https://doi.org/10.21203/rs.3.rs-618743/v1
Autor:
Aaron M. Allen, Ofer Rotem, Yosef Landman, Noga Kurman, Orly Yariv, Oded Jacobi, Alona Zer, Idit Peretz, Elizabeth Dudnik
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Oncoimmunology
article-version (VoR) Version of Record
Oncoimmunology
article-version (VoR) Version of Record
The standard of care for stage III non-small cell lung cancer (NSCLC) is chemoradiotherapy (CRT) followed by durvalumab. Although doses higher than 66 Gy are standard in our center, they were used in only 6.9% of patients in the PACIFIC trial. We rep
Autor:
Orly Yariv, Vadim Khasminsky, Elena Cogan, And Shlomit Yust-Katz, Alexandra Benouaich-Amiel, Hadar Goldvaser, Tali Siegal
Publikováno v:
Neuro Oncol
BACKGROUND Guillain-Barre syndrome (GBS) is an immune acute polyradiculoneuropathy usually presented as an ascending peripheral paresis with absent tendon reflex and albumino-cytologic dissociation on cerebrospinal fluid (CSF) exam.We describe two on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd40f1226d40ea12c57c51364563349f
https://europepmc.org/articles/PMC7651427/
https://europepmc.org/articles/PMC7651427/